Major corporations are reshaping their business strategies around weight loss drugs, signaling a massive shift in American consumer behavior that could fundamentally transform retail markets.
Story Highlights
- Target is expanding its protein and supplement sections in 2026 due to a surge in GLP-1 drug demand surge
- The weight loss medication market is projected to reach $150 billion by 2035
- Major brands like Nestlé and Conagra are creating GLP-1-specific product lines
- Retailers tracking social media influencers to predict consumer demand shifts
Target Leads Corporate Pivot to Weight Loss Drug Market
Target Corporation announced plans to expand shelf space for protein items and supplements in early 2026, responding directly to consumer demand driven by GLP-1 weight loss medications.
Lisa Roath, Target’s chief merchandising officer, revealed the company tracks cultural trends and influencer content to guide purchasing decisions. The retailer identified surging demand for protein and supplements as GLP-1 users seek nutritional support from the appetite-suppressing effects of these medications.
Target beefs up protein, supplement offerings, capitalizing on weight loss drug trend https://t.co/zCp4zpVZKy
— FOX Business (@FoxBusiness) December 10, 2025
Massive Market Transformation Underway
The weight loss medication market represents an unprecedented business opportunity, with Morgan Stanley projecting $150 billion in value by 2035. Currently, 8 million Americans use obesity drugs, but this number could reach 30 million by 2035, representing 20-25% of the obese population in an $80 billion market.
These medications, initially developed for diabetes treatment, have become highly sought for their weight-loss effectiveness, driving fundamental changes in consumer spending patterns.
Corporate Giants Race to Capture New Consumer Behaviors
Nestlé Health Science launched a specialized platform offering “holistic and personalized care” for GLP-1 users, focusing on preserving lean muscle mass and managing nutritional deficiencies.
Conagra Brands introduced “on track” badges identifying GLP-1-friendly products high in protein, low in calories, and rich in fiber. Danone North America created Oikos Fusion yogurt, marketed as the first product specifically designed for GLP-1 users’ unique nutritional challenges.
Beyond Food: Lifestyle Categories Experience Growth
Target reports expanding business across athletic wear and home fitness equipment as GLP-1 users adopt more active lifestyles following weight changes. The company observes consumers purchasing weights and fitness gear alongside their nutritional supplements, indicating comprehensive lifestyle transformations.
This trend represents a multi-category business opportunity that extends far beyond the traditional food and supplement sectors, affecting the apparel, fitness equipment, and wellness industries.
